MET Form 144: Holder plans NYSE sale of 30 MetLife shares
Rhea-AI Filing Summary
MetLife (MET) has a Form 144 notice covering a planned sale of common stock for the account of a reporting holder. The filing states that the holder intends to sell 30 shares of common stock through Barclays on the NYSE on or about 11/20/2025, with an aggregate market value of 2242.8. These 30 shares were acquired on 10/11/2021 via a purchase from Citigroup Global Markets, paid in cash on 10/13/2021.
The notice also lists other recent sales of the issuer’s common stock over the past three months by MetLife-related accounts, including 333 shares sold by MetLife 401k Plan Trust-Large Cap Equity Index on 10/01/2025 for gross proceeds of 27282.69 and 196 shares sold by MetLife 401k Plan Russell 1000 Value on 10/29/2025 for 15350.72. The signer represents that they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.